1-8 of 8
Lorenzo G. Mantovani
Close
Sort by
Journal Articles

Patient Preferences Regarding Anticoagulation Therapy in Patients with Cancer Having a VTE Event - a Discrete Choice Experiment in the Cosimo Study

Nils Picker, MSc, Alexander T Cohen, MBBS, MSc, MD, Anthony Maraveyas, MD PhD, Jan Beyer-Westendorf, MD, Agnes Yuet Ying Lee, MD MSc, FRCPC, Lorenzo G Mantovani, Yoriko De Sanctis, MS, Khaled Abdelgawwad, Samuel Fatoba, Miriam Bach, Thomas Wilke, Prof. Dr. rer. oec.
Journal: Blood
Blood (2019) 134 (Supplement_1): 2159.
https://doi.org/10.1182/blood-2019-128095
Published: 2019
Journal Articles

Baseline Characteristics and Clinical Outcomes from the Cancer Associated Thrombosis - Patient Reported Outcomes with Rivaroxaban (COSIMO) Trial

Anthony Maraveyas, MD PhD, Jan Beyer-Westendorf, MD, Agnes Yuet Ying Lee, MD MSc, FRCPC, Lorenzo G Mantovani, Yoriko De Sanctis, MS, Khaled Abdelgawwad, Samuel Fatoba, Miriam Bach, Alexander T Cohen, MBBS, MSc, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2161.
https://doi.org/10.1182/blood-2019-126810
Published: 2019
Journal Articles

A Pooled Analysis of the Xalia and Xalia-Lea Non-Interventional Studies of Rivaroxaban Versus Standard Anticoagulation in Venous Thromboembolism

Alexander G. G. Turpie, MD, Lorenzo G Mantovani, Sylvia Katharina Haas, MD PhD, Reinhold Kreutz, PhD, Danja Monje, Jonas Schneider, Martin van Eickels, Miriam Tamm, Martin Gebel, Walter Ageno
Journal: Blood
Blood (2017) 130 (Supplement 1): 2386.
https://doi.org/10.1182/blood.V130.Suppl_1.2386.2386
Published: 2017
Journal Articles

Incidence of Thrombo-Embolic Events in Relation to Activated Prothrombin Complex Concentrate Exposure: A Literature Meta-Analysis

Matteo Rota, Paolo A Cortesi, Roberto Crea, DVM, MSc, Alessandro Gringeri, MD PhD, Lorenzo G Mantovani
Journal: Blood
Blood (2017) 130 (Supplement 1): 1077.
https://doi.org/10.1182/blood.V130.Suppl_1.1077.1077
Published: 2017
Journal Articles

Subgroup Analysis of Patients with Cancer in Xalia - a Non-Interventional Study of Rivaroxaban in Routine Treatment of Deep Vein Thrombosis

Alexander G G Turpie, MD, Lorenzo G Mantovani, Sylvia Haas, Reinhold Kreutz, Danja Monje, Jonas Schneider, Martin van Eickels, Martin Gebel, Walter Ageno
Journal: Blood
Blood (2016) 128 (22): 1438.
https://doi.org/10.1182/blood.V128.22.1438.1438
Published: 2016
Journal Articles

Xalia, a Non-Interventional Study Comparing Rivaroxaban with Standard Anticoagulation for Initial and Long-Term Therapy in Deep Vein Thrombosis

Alexander G G Turpie, MD, Lorenzo G Mantovani, Sylvia Haas, Reinhold Kreutz, Danja Monje, Jonas Schneider, Martin van Eickels, Martin Gebel, Walter Ageno
Journal: Blood
Blood (2015) 126 (23): 894.
https://doi.org/10.1182/blood.V126.23.894.894
Published: 2015
Journal Articles

Meta-Analysis on Incidence of Inhibitors in 1,945 Previously Untreated Patients Treated with Recombinant Factor VIII Products: Is There a Difference?

Lorenzo G. Mantovani, Matteo Rota, Paolo Cortesi, Katharina Steinitz, Armin Reininger, Alessandro Gringeri
Journal: Blood
Blood (2015) 126 (23): 289.
https://doi.org/10.1182/blood.V126.23.289.289
Published: 2015
Journal Articles

Cost of care and quality of life for patients with hemophilia complicated by inhibitors: the COCIS Study Group

Clinical Trials & Observations
Alessandro Gringeri, Lorenzo G. Mantovani, Luciana Scalone, Pier Mannuccio Mannucci, the COCIS Study Group
Journal: Blood
Blood (2003) 102 (7): 2358–2363.
https://doi.org/10.1182/blood-2003-03-0941
Published: 2003